BioNTech

BioNTech pipeline news sparks renewed investor interest BioNTech pipeline news has captured the attention of investors and the biotech industry after a major regulatory milestone and promising progress within the company’s oncology portfolio. The latest developments have fueled a noticeable rally in BioNTech’s stock and strengthened confidence in its transition from a pandemic-driven vaccine producer…